BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 8.10.2002

Biological Response Modifiers Advisory Committee; Amendment of Notice

The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Biological Response Modifiers Advisory Committee. This meeting was originally announced in the Federal Register of September 27, 2002 (67 FR 61142). The amendment is being made to reflect a change in the Date and Time, Agenda, Procedure, Location, and Closed Committee Deliberations portions of the meeting. The meeting was originally scheduled as a teleconference on October 10, 2002, from 5:30 p.m. to 7:30 p.m. at the National Institutes of Health, Bldg. 29C, 29 Lincoln Dr., Bethesda, MD. FDA added a discussion topic related to retrovirus vectors in gene therapies for the treatment of patients with severe combined immune deficiency disease to the meeting and the meeting will be held on October 10 at the Hilton DC North-- Gaithersburg, 620 Perry Pkwy., Gaithersburg, MD from 8 a.m. to 5 p.m.

Source: Federal Register — Food and Drug AdministrationOpen original release →